One-electron reduction of 17-(Dimethylaminoethylamino)-17- demethoxygeldanamycin: A pulse radiolysis study

Sara Goldstein*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

Geldanamycin, a benzoquinone ansamycin antibiotic, is a natural product inhibitor of Hsp90 with potent and broad anticancer properties but with unacceptable levels of hepatotoxicity. Consequently, numerous structural analogs, which differ only in their 17-substituent, have been synthesized including the water-soluble and less toxic 17-(dimethylaminoethylamino)-17- demethoxygeldanamycin (17-DMAG, Alvespimycin). It has been suggested that the different hepatotoxicity reflects the redox active properties of the quinone moiety. The present pulse radiolysis study was aimed at studying the one-electron reduction of 17-DMAG. The UV-visible spectrum of the semiquinone radical, its pK a, and the second-order rate constants for the reactions of 17-DMAG with CO 2 •- and (CH 3) 2C OH have been obtained. The reduction potential of 17-DMAG has been determined to be -194 ± 6 mV (vs NHE) using oxygen, 1,4-naphthoquinone, and menadione as electron acceptors. This reduction potential is lower than that of O 2 demonstrating that thermodynamically the semiquinone radical can reduce O 2 to superoxide, particularly since the concentration of O 2 is expected to exceed that of the drug in cells and tissues.

Original languageEnglish
Pages (from-to)8928-8932
Number of pages5
JournalJournal of Physical Chemistry A
Volume115
Issue number32
DOIs
StatePublished - 18 Aug 2011

Fingerprint

Dive into the research topics of 'One-electron reduction of 17-(Dimethylaminoethylamino)-17- demethoxygeldanamycin: A pulse radiolysis study'. Together they form a unique fingerprint.

Cite this